Related Experiment Video
Updated: May 10, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Ethics and pre-exposure prophylaxis for HIV infection
Jeremy Sugarman1, Kenneth H Mayer
1Berman Institute of Bioethics, Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. jsugarman@jhu.edu
Antiretroviral agents (ARVs) show promise for HIV prevention, but ethical considerations like well-being and justice are crucial for their appropriate use in practice and research.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Bioethics
Background:
- Antiretroviral agents (ARVs) are increasingly recognized for their potential in preventing HIV infection.
- The U.S. Food and Drug Administration (FDA) approved tenofovir-emtricitabine as pre-exposure prophylaxis (PrEP), with guidance issued by regulatory bodies.
- Clinicians, policymakers, and individuals at risk face decisions regarding the use of ARVs for HIV prevention.
Purpose of the Study:
- To identify and analyze the ethical dimensions surrounding the use of ARVs for HIV prevention, specifically pre-exposure prophylaxis (PrEP).
- To explore ethical issues related to well-being (safety, use, risk behaviors, resistance, stigma, diversion) and justice (access, competing priorities) in PrEP implementation.
- To address ethical considerations for incorporating PrEP into future HIV prevention research, including control arm selection and participant prevention packages.
Main Methods:
- Ethical analysis of pre-exposure prophylaxis (PrEP) for HIV prevention.
- Review of current evidence and regulatory guidance on ARV use for prophylaxis.
- Identification of ethical domains: well-being and justice.
Main Results:
- Key ethical considerations for PrEP use include safety, appropriate parameters, risk behaviors, potential for resistance, stigma, and diversion.
- Justice-related ethical issues encompass equitable access to PrEP and the prioritization of resources.
- Ethical challenges in PrEP research involve determining appropriate control groups and the provision of PrEP within prevention packages.
Conclusions:
- Understanding and addressing the ethical issues of well-being and justice is critical for the safe, effective, and appropriate implementation of PrEP.
- Ethical considerations must guide both the clinical application and future research of ARVs as a tool for HIV prevention.
- Proactive ethical evaluation is essential for maximizing the public health impact of PrEP while upholding individual rights and societal values.
Related Concept Videos
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Sexually Transmitted Infections
Ethics in Research
Ethics and Bioethics
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

